about
Nonconvulsive status with metronidazoleRole of anesthesia for endovascular treatment of ischemic stroke: do we need neurophysiological monitoring?Refractory and super-refractory status epilepticus--an update.The safety of lacosamide for treatment of seizures and seizure prophylaxis in adult hospitalized patientsTherapeutic hypothermia for neuroprotection: history, mechanisms, risks, and clinical applications.A 'spicy' encephalopathy: synthetic cannabinoids as cause of encephalopathy and seizureInvited article: is it time for neurohospitalists?The future of health care: going to the dogs?Gender differences in presenting signs and symptoms of acute ischemic stroke: a population-based studyHeart-Shaped Bilateral Medullary Pyramidal Infarction as a Pathognomonic Finding of Anterior Spinal Artery Occlusion.Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.Future neurohospitalist: teleneurohospitalist.The Workforce Task Force report: clinical implications for neurologySafety of intraventricular hemorrhage (IVH) thrombolysis based on CT localization of external ventricular drain (EVD) fenestrations and analysis of EVD tract hemorrhage.Stroke prevention in atrial fibrillation and other major cardiac sources of embolism.The ABC's of stroke complications.Hypoxic-ischemic brain injury and prognosis after cardiac arrest.New approaches to bedside monitoring in stroke.Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension.Effect of therapeutic hypothermia on gas exchange and respiratory mechanics: a retrospective cohort study.SPECT-negative SIRPIDs: less aggressive neurointensive care?Emerging role of cardiovascular CT and MRI in the evaluation of stroke.Precision medicine of aneurysmal subarachnoid hemorrhage, vasospasm and delayed cerebral ischemia.Cerebral Venous Thrombosis Associated with Intracranial Hemorrhage and Timing of Anticoagulation after Hemicraniectomy.Novel Bedside Phonetic Evaluation to Identify Dysphagia and Aspiration Risk.Diaphragmatic pacing to facilitate ventilator weaning in neuromyelitis optica-associated respiratory failure.Ambulance-based assessment of NIH Stroke Scale with telemedicine: A feasibility pilot study.The future of neurology.The utility of serum procalcitonin in distinguishing systemic inflammatory response syndrome from infection after aneurysmal subarachnoid hemorrhage.Safety of percutaneous tracheostomy in NeuroICU patients with intracranial pressure monitoringHeadache and Its Approach in Today's NeuroIntensive Care Unit.Very early mobilization in stroke patients treated with intravenous recombinant tissue plasminogen activator.Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus.ICU vampires and anemia.Relationship of Troponin T and Age- and Sex-Adjusted BNP Elevation Following Subarachnoid Hemorrhage with 30-Day Mortality.Influence of body mass index and age on functional outcomes in patients with subarachnoid hemorrhage.The "starfield" pattern of cerebral fat embolism from bone marrow necrosis in sickle cell crisisA 51-year-old man with seizures and progressive behavioral changes.Multimodal CT to Differentiate Acute Ischemic Stroke From Stroke Mimics.Expertise Matters.
P50
Q27004125-B09BC2C4-17AC-4363-8B85-F5B9E2D93C46Q27009236-B75B6EC2-1978-4D2C-AFBA-222BD0FDF775Q30807706-A3D0A8A2-52F4-48E8-B847-316865E21976Q33410040-725496D6-26CB-4971-906E-942A6CADB0E3Q33751306-11DBCF85-8272-4625-8272-A71E32258256Q34364919-FAA9E6C6-A33C-41E9-AD69-22C5EFC6042CQ34761265-29837A25-CBCE-4779-B993-B7080DF8302DQ35584984-1BB18BEE-D08A-43DE-98DD-9EF02EB23689Q35883814-B422522F-EA24-44D1-B73E-6092C1F5B467Q36366586-E395C0BE-BFE8-4544-819C-61B944E5A9CCQ36730433-7F595F7B-C72D-4BAC-945A-30989DF9E36FQ37052779-2A80179D-1B04-4B7C-8F5D-CA57EC19C5AFQ37181109-A53D90AD-D7BB-4B22-9047-17ED65FE2F6EQ37202908-7D048A30-6146-4776-A4CB-ECCDE5706F6FQ37332375-03DDB1D9-4E8C-4457-A21D-81F1904080C1Q37826147-42FD8554-83FA-4365-86C5-7DE604B85C69Q38027285-5E2D0D24-6E7E-46F9-B658-2AD574BF1B34Q38045908-693532AA-8222-41F4-B38E-9195BD6CBC86Q38136540-FF4227E3-BF85-4835-8F4D-70F86ADC3707Q38212779-D8833E2B-C45C-4823-9980-DDDEF8EF8814Q38216797-AC0711A4-3EB2-45E7-ADBB-A3968B767E6BQ38330054-1AB919A1-4B68-4C09-BCE3-AC1E3B926CC6Q38868254-C69F9BFB-5081-4D62-A116-BDBD3722C2A1Q38870419-20FE34D2-0FD9-4B1A-9AD1-35CA4D6CADB0Q38981866-BC42FD61-FB47-474C-B065-51A8CF0071EAQ39223795-21F4353E-10B0-4290-BF6F-9D481213CBA1Q39767732-3C4783D8-AE6B-4356-8F71-485196B4683EQ39895100-D5407273-F670-48B2-B546-E9BB385FDCE0Q40218016-6AECEDC4-9791-49A0-BEBA-276BAAA9F815Q40655214-88B6BB8B-215D-420E-8D8D-F6DC51414C39Q40746576-ED64F230-AA7A-40F7-91ED-56336E0F12E7Q41078693-8DF02B83-3541-4549-9180-2513973D71E1Q41318447-0092C32D-32C1-4D67-AA46-76EF8BEB33C3Q41326048-65A3C88E-BE16-4E3A-94B9-23110C236DF9Q41585141-8C8E7270-CC4D-4B24-A70F-0C8AE3B639E9Q41639277-C8A34B3D-C405-4417-A732-AA78C6B24CFAQ41904541-A0CA1851-E81B-4BC1-B53A-3A172C59231BQ42158148-270F1861-EE24-4B67-8CCC-2A31B15E363BQ42557306-2C4CCDAC-58ED-4989-BA8F-92839AB6E183Q42716095-F2185DB6-6263-4115-8A1A-D94CBB7A2721
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
William D Freeman
@nl
William D Freeman
@sl
William D. Freeman
@en
William D. Freeman
@es
type
label
William D Freeman
@nl
William D Freeman
@sl
William D. Freeman
@en
William D. Freeman
@es
altLabel
W D Freeman
@en
prefLabel
William D Freeman
@nl
William D Freeman
@sl
William D. Freeman
@en
William D. Freeman
@es
P106
P1153
26643459000
P21
P31
P496
0000-0003-2326-0633